Cargando…
Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.
A genetically reshaped human IgG1 monoclonal antibody (Hu2PLAP) with anti-tumour specificity, was radiolabelled with Indium-111 by chelation with a new macrocyclic compound (DOTA) which allows the production of stable radioimmunoconjugates for in vivo application. This was used to image seven patien...
Autores principales: | Hird, V., Verhoeyen, M., Badley, R. A., Price, D., Snook, D., Kosmas, C., Gooden, C., Bamias, A., Meares, C., Lavender, J. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977456/ https://www.ncbi.nlm.nih.gov/pubmed/1931615 |
Ejemplares similares
-
Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody.
por: Hird, V., et al.
Publicado: (1993) -
Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.
por: Harwood, P. J., et al.
Publicado: (1985) -
Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA.
por: Allum, W. H., et al.
Publicado: (1986) -
Radioactive Source Localisation via Projective Linear Reconstruction
por: White, Samuel R., et al.
Publicado: (2021) -
Iodinated hydroxyphenyl and hydroxynaphthyl porphyrins as tumour localisers.
por: Zanelli, G. D., et al.
Publicado: (1990)